This CEBPD and MYC‐centric multilayered positive feedback loop enhances oncogenic glycolysis, which ensures cancer growth, especially during glucose metabolism dysregulation, indicating that it could be a target for combined treatment strategies. The gene discussed is CEBPD; the disease is cancer.